A Ternary Ni46 Co40 Fe14 Nanoalloy-Based Oxygen Electrocatalyst for Highly Efficient Rechargeable Zinc-Air Batteries

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 30(2018), 46 vom: 15. Nov., Seite e1803372
1. Verfasser: Nam, Gyutae (VerfasserIn)
Weitere Verfasser: Son, Yeonguk, Park, Sung O, Jeon, Woo Cheol, Jang, Haeseong, Park, Joohyuk, Chae, Sujong, Yoo, Youngshin, Ryu, Jaechan, Kim, Min Gyu, Kwak, Sang Kyu, Cho, Jaephil
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Zn-air batteries oxygen evolution reaction oxygen reduction reaction supercritical reactions ternary nanoalloys
Beschreibung
Zusammenfassung:© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Replacing noble-metal-based oxygen reduction reaction (ORR) and oxygen evolution reaction (OER) electrocatalysts is the key to developing efficient Zn-air batteries (ZABs). Here, a homogeneous ternary Ni46 Co40 Fe14 nanoalloy with a size distribution of 30-60 nm dispersed in a carbon matrix (denoted as CNCF-900) as a highly efficient bifunctional electrocatalyst produced via supercritical reaction and subsequent heat treatment at 900 °C is reported. Among all the transition-metal-based electrocatalysts, the C@NCF-900 exhibits the highest ORR performance in terms of half-wave potential (0.93 V) in 0.1 m KOH. Moreover, C@NCF-900 exhibits negligible activity decay after 10 000 voltage cycles with minor reduction (0.006 V). In ZABs, C@NCF-900 outperforms the mixture of Pt/C 20 wt% and IrO2 , cycled over 100 h under 58% depth of discharge condition. Furthermore, density functional theory (DFT) calculations and in situ X-ray absorption spectroscopy strongly support the active sites and site-selective reaction as a plausible ORR/OER mechanism of C@NCF-900
Beschreibung:Date Completed 13.11.2018
Date Revised 30.09.2020
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.201803372